Press Release &ndash   UPDATE ON BIOLIDICS CLEAREPI SARS-COV-2 NEUTRALISING ANTIBODY RAPID TEST KIT
- Biolidics has entered into a definitive manufacturing agreement for the production of its ClearEpi SARS-CoV-2 Neutralising Antibody Rapid Test Kit (the " ClearEpi NAB Test" ) and obtained the relevant product liability insurance
- Unlike most commercially available COVID-19 serology tests which test for IgM/ IgG antibodies in patients, the ClearEpi NAB Test, developed by Biolidics with technology licensed from the Agency for Science, Technology and Research (" A*STAR" )&rsquo s Accelerate Technologies Pte Ltd (&ldquo A*ccelerate&rdquo ), provides results that may indicate an individual' s protective immunity against COVID-19
- Neutralising antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection1 &bull The ClearEpi NAB Test can potentially serve as an important tool to assist in the area of assessing vaccine efficacy, vaccine deployment and social activities management (such as air travel2 ), among others
- The commercialisation of ClearEpi NAB Test is another Singapore medical technology innovation that showcases the strong collaborative partnerships between Singapore public agencies and the private sector
- The ClearEpi NAB Test has obtained the CE marking that allows it to be marketed and sold in the European Union
https://links.sgx.com/1.0.0/corporate-announcements/GCOY1G5S1ZBSPDTS/693682_Biolidics%20Announcement%20-%20NAB%20Update%20-%20Final.pdf
- Biolidics has entered into a definitive manufacturing agreement for the production of its ClearEpi SARS-CoV-2 Neutralising Antibody Rapid Test Kit (the " ClearEpi NAB Test" ) and obtained the relevant product liability insurance
- Unlike most commercially available COVID-19 serology tests which test for IgM/ IgG antibodies in patients, the ClearEpi NAB Test, developed by Biolidics with technology licensed from the Agency for Science, Technology and Research (" A*STAR" )&rsquo s Accelerate Technologies Pte Ltd (&ldquo A*ccelerate&rdquo ), provides results that may indicate an individual' s protective immunity against COVID-19
- Neutralising antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection1 &bull The ClearEpi NAB Test can potentially serve as an important tool to assist in the area of assessing vaccine efficacy, vaccine deployment and social activities management (such as air travel2 ), among others
- The commercialisation of ClearEpi NAB Test is another Singapore medical technology innovation that showcases the strong collaborative partnerships between Singapore public agencies and the private sector
- The ClearEpi NAB Test has obtained the CE marking that allows it to be marketed and sold in the European Union
https://links.sgx.com/1.0.0/corporate-announcements/GCOY1G5S1ZBSPDTS/693682_Biolidics%20Announcement%20-%20NAB%20Update%20-%20Final.pdf
Unfortunately, the system doesn' t favour contra players for low liquidity stocks. Sometimes these stocks are only a one day wonder and those contra plyrs who bought at or near the highs will suffer when contra date is due and forced to sell to the available buyer out there.
Today Bio closed at 0.168 which is even lower than before the run up this Mon.   
Caution required and strict CL to avoid getting into a mess when trading such stocks.
Dyodd 
 
Today Bio closed at 0.168 which is even lower than before the run up this Mon.   
Caution required and strict CL to avoid getting into a mess when trading such stocks.
Dyodd 
 
slingshotpro ( Date: 03-Dec-2021 10:19) Posted:
|
This Contra system destroys shareholder?s value.
niteowl68 ( Date: 30-Nov-2021 11:43) Posted:
|
Those who chased this counter and bought thinking of contra are in for a rude shock as buy vol is thin after the euphoria. To contra off 200 lots may bring the price down several bids eg. 187 to 179.. one must be able to pick up and hold this counter for mid term in order to profit from it. Dyodd 
Cleared all my holdings at 21... not bad run.  Now correction in progress after the euphoria yest.. Will wait at 0.17x to collect back. Huat Ah! Dyodd
niteowl68 ( Date: 25-Oct-2021 09:51) Posted:
|
Both biolidics and clearbridge charts look good for run, usually both can chiong together.
Lets see if they can test their all time high.
Lets see if they can test their all time high.
Possible ? Mmmm not many players in bio or clearbridge I bought CB
next in play
Huh? This one also join for fun ?
Lai liao....playing catching up with the gloves maker
back to 20 soon
Medical stocks rebounding today....
All the dumping.....
is this counter dead?
Firming up.. I better park some before it start to cheong.. huat ah! Dyodd
Good potential for their new product as more and more countries are opening up and learning how
to live with Covid. I believe good news akan datang.. Huat ahh! Dyodd
to live with Covid. I believe good news akan datang.. Huat ahh! Dyodd
No worries, medical stocks will rebound strongly for the coming weeks. Most are over sold..
LZLOmega ( Date: 22-Oct-2021 16:18) Posted:
|
Help me!!!!
On the brightside they are playing the 100 game now. We might see a rise tmr.
Starship ( Date: 20-Oct-2021 11:01) Posted:
|

LZLOmega ( Date: 20-Oct-2021 10:55) Posted:
|